Artificial reproductive technology and the risk of venous thromboembolic disease

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 8, 2006, Pages 1661-1663

  Nelson, S M ^a   Greer, I A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; DALTEPARIN; ENOXAPARIN; ESTROGEN; GONADOTROPIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN;

AGE DISTRIBUTION; ARM DISEASE; BLEEDING TENDENCY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ESTROGEN SYNTHESIS; FAMILY HISTORY; FEMALE; FRAGILITY FRACTURE; GESTATIONAL AGE; HEART OUTPUT; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; INFERTILITY THERAPY; LEG COMPRESSION; LOW DRUG DOSE; LUNG EMBOLISM; MEDICAL LITERATURE; NOTE; ORAL CONTRACEPTION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; THROMBOPHILIA; UPREGULATION; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; MALE; OVARIAN HYPERSTIMULATION SYNDROME; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 33746590223     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02062.x     Document Type: Note

References (14)

1. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper-extremity deep vein thrombosis: A prospective registry of 592 patients. Circulation 2004; 110: 1605-11.
2. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: Unmasking the 'ART' behind the clot. J Thromb Haemost 2006; 4: 1673-7.
3. Clark P, Greer IA. Practical Obstetric Hematology. Oxford, UK: Taylor & Francis, 2006.
4. Broughton Pitkin F. Turnbull's Obstetrics, 3rd edn. London, UK: Harcourt Publisher Ltd, 2001.
5. Nyboe Andersen A, Gianaroli L, Nygren KG, European Society of Human Reproduction and E. Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE. Hum Reprod 2004; 19: 490-503.
6. Aune B, Hoie KE, Oian P, Holst N, Osterud B. Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state ? Hum Reprod 1991; 6: 925-7.
7. Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupferminc MJ. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod 2004; 19: 368-70.
8. Whelan JG III, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 883-96.
9. Baumann P, Diedrich K. Thromboembolic complications associated with reproductive endocrinologic procedures. Hematol Oncol Clin North Am 2000; 14: 431-43.
10. Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington KF, Nelson-Piercy C, Parsons JH. Internal jugular vein thrombosis after assisted conception therapy. Br J Haematol 2001; 115: 153-5.
11. Fabregues F, Tassies D, Reverter JC, Carmona F, Ordinas A, Balasch J. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004; 81: 989-95.
12. Bates S, Greer IA, Ginsberg J, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2004; 126 (3 Suppl.): 627S-44S.
13. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401-7.
14. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999; 353: 1258-65.